
During the last two decades the zzso of systemic zzso infections has been rising zzso The prognosis of infected patients is often poor and the therapeutic strategies are zzso The prophylaxis of systemic zzso infections thus appears zzso The substances available comprise the zzso zzso and zzso and the zzso zzso B and zzso If zzso infections are to be targeted zzso can be zzso The adequate dose is 400 zzso zzso Compliance usually is satisfactory and zzso adverse events are zzso zzso covers a broader spectrum which encompasses all relevant zzso zzso and oral solution of zzso do not achieve reliably the therapeutic serum level of about 500 zzso An intravenous zzso of zzso has recently been approved in the United States, but there is a zzso of data with regard to its zzso zzso zzso zzso zzso medication may result in life-threatening zzso zzso intravenous zzso B has been proven effective for zzso Due its toxicity profile zzso zzso B should be used only for selected cases and in clinical zzso zzso can be used zzso whenever topical zzso B is not well zzso All currently available zzso zzso bear the risk of either unsatisfactory effectiveness or severe zzso 

